(Q39039214)

8 September 2017

The relevance of gender in Parkinson's disease: a review (English)

1 reference

8 September 2017

1 reference

Barbara Garavaglia

4

0 references

Marina Picillo

object named as

Marina Picillo

series ordinal

1

0 references

Paolo Barone

series ordinal

5

object named as

Paolo Barone

1 reference

PubMed ID

28054129

8 September 2017

Maria Teresa Pellecchia

series ordinal

6

object named as

Maria Teresa Pellecchia

1 reference

8 September 2017

2

Alessandra Nicoletti

1 reference

8 September 2017

Vincenza Fetoni

3

1 reference

8 September 2017

4 January 2017

1 reference

8 September 2017

1 reference

8 September 2017

264

1 reference

8 September 2017

8

1 reference

8 September 2017

1583-1607

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-016-8384-9

8 September 2017

0 references

cites work

Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Twenty years and still counting: including women as participants and studying sex and gender in biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Sex differences in Alzheimer's disease and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Are men at greater risk for Parkinson's disease than women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Heterogeneity in male to female risk for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Sex and Parkinson's disease: a world of difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The prevalence of Parkinson's disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Mortality in Parkinson's disease: a 38-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Parkinson's disease and risk of mortality: meta-analysis and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Reproductive factors and clinical features of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Ethnicity, socio-economic position and gender--do they affect reported health-care seeking behaviour?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Diagnosis and referral delay in women with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Risk and course of motor complications in a population-based incident Parkinson's disease cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Classifying risk factors for dyskinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender effect on time to levodopa-induced dyskinesias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences on motor and non-motor symptoms of de novo patients with early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Risk of Parkinson disease after depression: a nationwide population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease--a study from Southwest China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender and non motor fluctuations in Parkinson's disease: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Predictors of dementia in Parkinson disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Longitudinal study of normal cognition in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Dementia in Parkinson's disease: Is male gender a risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender effect on non-motor symptoms in Parkinson's disease: are men more at risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in Parkinson's disease: focus on plasma α-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Urate as a predictor of the rate of clinical decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Serum urate and probability of dopaminergic deficit in early "Parkinson's disease".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Low serum uric acid concentration in Parkinson's disease in southern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Postmortem brain levels of urate and precursors in Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Prospective study of plasma urate and risk of Parkinson disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Association of the mt-ND2 5178A/C polymorphism with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The homozygote AA genotype of the alpha1-antichymotrypsin gene may confer protection against early-onset Parkinson's disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

CCDC62 variant rs12817488 is associated with the risk of Parkinson's disease in a Han Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Association between sex, systemic iron variation and probability of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The single nucleotide polymorphism Rs12817488 is associated with Parkinson's disease in the Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Non-SMC condensin I complex, subunit D2 gene polymorphisms are associated with Parkinson's disease: a Han Chinese study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in the risk of familial parkinsonism: beyond LRRK2?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender and the Parkinson's disease phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Large differences in levodopa dose requirement in Parkinson's disease: men use higher doses than women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Sex differences in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Sex differences in the pharmacokinetics of levodopa in elderly patients with Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The "brittle response" to Parkinson's disease medications: characterization and response to deep brain stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Disparities in access to deep brain stimulation surgery for Parkinson disease: interaction between African American race and Medicaid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Disparities in deep brain stimulation surgery among insured elders with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender distribution of patients with Parkinson's disease treated with subthalamic deep brain stimulation; a review of the 2000-2009 literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The decision-making process leading to deep brain stimulation in men and women with parkinson's disease - an interview study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in disability and health-related quality of life in patients with Parkinson's disease treated with stereotactic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender influence on selection and outcome of deep brain stimulation for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in quality of life following subthalamic stimulation for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Transient gender-related effects in Parkinson's disease patients with subthalamic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Deep Brain Stimulation during Pregnancy and Delivery: Experience from a Series of "DBS Babies".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Sex differences in Parkinson's disease and other movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Sex differences in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Parkinson's disease and reproductive life events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Postmenopausal estrogen use affects risk for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Risk of Parkinson disease in women: effect of reproductive characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Caffeine, postmenopausal estrogen, and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Increased risk of parkinsonism in women who underwent oophorectomy before menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Number of children and risk of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Exposure to estrogen and women's risk for Parkinson's disease: a prospective cohort study in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Reproductive factors and Parkinson's disease risk in Danish women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Female reproductive factors, menopausal hormone use, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Lifetime exposure to estrogens and Parkinson's disease in California teachers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Hormonal replacement therapy in women with Parkinson disease and levodopa-induced dyskinesia: a crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

How much does sex matter in Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Sex Differences in Clinical Features of Early, Treated Parkinson's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Sex differences in cognition among Chinese people with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in Parkinson's disease symptom profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Baseline predictors of worsening apathy in Parkinson's disease: A prospective longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

The risk of Parkinson disease associated with urate in a community-based cohort of older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Gender differences in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8384-9

Survival in Parkinson's disease. Relation with motor and non-motor features.

21 January 2018

1 reference

12 December 2020

Effects of female sex steroids on Parkinson's disease in postmenopausal women.

1 reference

12 December 2020

Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women

1 reference

12 December 2020

Reproductive factors and Parkinson's disease: A multicenter case-control study

1 reference

12 December 2020

Increased DJ-1 in urine exosome of Korean males with Parkinson's disease

1 reference

12 December 2020

Gender differences in Parkinson's disease

1 reference

12 December 2020

The "gender factor" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study.

1 reference

12 December 2020

Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease

1 reference

12 December 2020

Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations

1 reference

12 December 2020

10.1007/S00415-016-8384-9

Identifiers

DOI

1 reference

8 September 2017

1 reference

PubMed ID

28054129